Millennium Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Millennium Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-115,100	Closed	-$2.02M	–	7809
2021 Q3	$2.02M	Buy	+115,100	New	+$1.34M	﹤0.01%	3910
2021 Q2	–	Sell	-24,000	Closed	-$258K	–	7391
2021 Q1	$258K	Buy	+24,000	New	+$297K	﹤0.01%	5319

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Millennium Management's TRIL Position: Q4 2021 in Review

Millennium Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 553,684 shares — an estimated $9.73M sold.

Millennium Management first reported a position in TRIL in Q2 2015 and held it in 19 quarters. The position peaked at $12.8M in Q4 2020. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Millennium Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Millennium Management sold 553,684 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $9.73M.
Millennium Management first reported a position in Trillium Therapeutics Inc. in Q2 2015 and held it in 19 quarters.
Millennium Management's Trillium Therapeutics Inc. position peaked at $12.8M in Q4 2020.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.